肝がんにおけるTHOC5発現の上昇と,腫瘍の進行および治療応答に対するその影響
PubMedで要約を見る
まとめ
この要約は機械生成です。THOC5遺伝子は肝がんを含む多くの癌で過剰発現し 患者の生存率を予測します THOC5をターゲットにすることで,がん患者のための新しい治療戦略を提供することができます.
科学分野
- 腫瘍学
- 分子生物学
- 遺伝学
背景
- 癌の発生率は環境要因によって上昇しています.
- THO複合体の一部であるTHOC5遺伝子は,がん生物学に関与しています.
- THOC5の役割を理解することは新しいがん治療法の開発に不可欠です.
研究 の 目的
- 様々な癌のTHOC5遺伝子発現を調査する.
- がん,特に肝臓細胞癌 (LIHC) のTHOC5の予後的意義を決定する.
- LIHCにおける潜在的な治療目標としてTHOC5を調査する.
主な方法
- THOC5発現と予後に関する公的ながんデータセットの分析
- 単細胞RNA配列解析,RNA配列解析,免疫ヒストケミストリー,およびLIHCにおけるプロテオミクスを用いた検証.
- LIHC細胞におけるTHOC5ノックダウン後の機能検査 (創傷治癒,トランスウェル移動)
- THOC5発現に関連した薬物感受性分析
主要な成果
- THOC5は複数の癌で過剰に発現し,予後が悪いと相関しています.
- LIHCにおけるTHOC5 mRNAとタンパク質の上昇は,進行したステージと生存率の低下に関連しています.
- THOC5のノックダウンにより,LIHC細胞の増殖,移動,侵入をインビトロで抑制した.
- 高いTHOC5発現は,免疫細胞の浸透と特定の化学療法に対する感受性の増加と関連しているが,免疫療法に対する反応は弱かった.
結論
- THOC5は,LIHCおよび他のがんにおける予後バイオマーカーおよび潜在的な治療標的として機能する.
- THOC5をターゲットにすると,特に免疫療法が効果的でない場合,代替治療の選択肢が提供されます.
- THOC5主導の経路 (EGFR,低酸素,MAPKなど) に関するさらなる研究は,新しい治療戦略を明らかにする可能性があります.
関連する概念動画
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

